AstraZeneca PLC

AstraZeneca hikes earnings forecast as surging cancer drug sales offset plunging revenue from COVID vaccines

11:22 a.m. Nov. 9, 2023

- Louis Goss

AMD, Kraft Heinz stocks surge, WeWork and CVS shares sink and other stocks on the move

12:53 p.m. Nov. 1, 2023

- MarketWatch

Cellectis’ stock is the biggest gainer and most active premarket after equity investment, collaboration pact with AstraZeneca

6:29 a.m. Nov. 1, 2023

- Tomi Kilgore

AstraZeneca said U.S. FDA has accepted for review its Flumist self-administered flu vaccine

6:21 a.m. Oct. 24, 2023

- Ciara Linnane

Here’s what Ozempic, ASML and India’s fintech industry all have in common — and how one ETF takes advantage of all three

9:04 a.m. Oct. 17, 2023

- Philip van Doorn

Startup Cerebras stands out in the high-risk AI chip arena: ‘No one has built a chip this big’

6:44 p.m. Oct. 11, 2023

- Therese Poletti

This fund shows that industry expertise can help you make a lot of money in the stock market

11:28 a.m. Oct. 2, 2023

- Philip van Doorn

JPMorgan says the coming energy crisis may be worse than what Europe experienced

6:22 a.m. Sept. 22, 2023

- Steve Goldstein

CDC panel says babies should get new drug that prevents RSV

7:17 p.m. Aug. 3, 2023

- Associated Press

As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion

4:05 a.m. July 21, 2023

- Steve Goldstein

AstraZeneca shares slump after Phase 3 lung cancer drug study

7:35 a.m. July 3, 2023

- Steve Goldstein

AstraZeneca shares slump after Phase 3 lung cancer drug study

4:36 a.m. July 3, 2023

- Steve Goldstein

AstraZeneca to decarbonize its U.S. footprint by turning cow manure into renewable natural gas

9:21 a.m. June 13, 2023

- Rachel Koning Beals

How a nasal vaccine could reduce the risk of COVID infections — and new variants

7:31 a.m. March 17, 2023

- Jaimy Lee

FTSE 100 hits fresh record above 8,000 on weak pound and renewed demand for energy stocks

10:08 a.m. Feb. 16, 2023

- Jamie Chisholm

Omicron strains remain dominant globally, and the WHO is monitoring four closely

2:50 p.m. Feb. 9, 2023

- Ciara Linnane

AstraZeneca’s preventive COVID therapy no longer effective against current variants

1:49 p.m. Jan. 26, 2023

- Jaimy Lee

Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns than research

1:40 p.m. Jan. 14, 2023

- Ciara Linnane

Is pharma M&A making a comeback?

7:22 a.m. Jan. 13, 2023

- Jaimy Lee

FDA approves AstraZeneca’s new treatment for people with asthma

8:38 a.m. Jan. 11, 2023

- Jaimy Lee

Roche’s Immunotherapy Drug Extended Patients’ Lives

9:20 p.m. Dec. 7, 2017

- The Wall Street Journal Interactive Edition

In U.K., Barriers Rising Against Foreign Deals

9:28 a.m. May 11, 2015

- The Wall Street Journal Interactive Edition

Celgene Profit Surges, Driven by Revlimid Sales

7:18 a.m. April 30, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca Reports Fall in First-Quarter Profit

7:26 a.m. April 24, 2015

- The Wall Street Journal Interactive Edition

Billion-Dollar Health Startups

4:21 p.m. Feb. 27, 2015

- The Wall Street Journal Interactive Edition

Valeant to Buy Salix for About $10 Billion

8:44 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

New Cancer Technology Cheers Investors

3:35 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

Valeant Nears Deal to Buy Salix

1:58 p.m. Feb. 22, 2015

- The Wall Street Journal Interactive Edition

Actavis Changing Name to Allergan

11:24 a.m. Feb. 18, 2015

- The Wall Street Journal Interactive Edition

Pharma Must Launch Itself Back

7:17 p.m. Feb. 16, 2015

- The Wall Street Journal Interactive Edition

Corporate Watch: News Digest

11:42 p.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca Deals Up a Tricky 2015

11:55 a.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

Pfizer to Buy Hospira for $16 Billion

10:22 a.m. Feb. 6, 2015

- The Wall Street Journal Interactive Edition

Astra to Buy Actavis Portfolio

6:54 a.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

New Outsourcing Frontier in India: Monitoring Drug Safety

10:20 p.m. Feb. 2, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca to Harness Benefits of Genome-Editing Technology

6:06 a.m. Jan. 29, 2015

- The Wall Street Journal Interactive Edition

Pfizer Sales Hit by Stronger Dollar

9:53 p.m. Jan. 27, 2015

- The Wall Street Journal Interactive Edition

Teva: FDA Approves Generic Version of AstraZeneca Heartburn Drug

5:07 p.m. Jan. 26, 2015

- The Wall Street Journal Interactive Edition

Peter Wallenberg Dies at 88

3:26 p.m. Jan. 19, 2015

- The Wall Street Journal Interactive Edition

Pharma Grows Itself a New Challenge -- Overheard

6:51 p.m. Jan. 13, 2015

- The Wall Street Journal Interactive Edition